The Xi’An International Medical Investment Company Limited(000516) caught in the vortex of “pregnant women’s abortion” can be described as “house leakage happens every night”. Since January 5 and closing on January 14, it has fallen by more than 25% in eight trading days. On January 13, Xi’An International Medical Investment Company Limited(000516) was warned by the exchange of other risks. The trading of stocks will be suspended for one day from the opening of the market on January 14, 2022 and resumed from the opening of the market on January 17, 2022, The stock abbreviation of the company is changed from ” Xi’An International Medical Investment Company Limited(000516) ” to “St Guoyi”.
Moreover, on the day of suspension (January 14), Xi’An International Medical Investment Company Limited(000516) was collectively “compensated” by fund companies. Two fund companies, including Bank of China and GF, adjusted the valuation of Xi’An International Medical Investment Company Limited(000516) held by their funds to 7.11 yuan at the same time, down 15.05% from the closing price of 8.37 yuan on January 13. CITIC Prudential and Golden Eagle Fund followed up to adjust the valuation this weekend, This also means that the fund company expects Xi’An International Medical Investment Company Limited(000516) to resume trading next week with at least one limit.
four fund companies successively reduced Xi’An International Medical Investment Company Limited(000516) valuation
down to 7.11 yuan / share
On the day of suspension on January 14, a number of fund companies with Xi’An International Medical Investment Company Limited(000516) positions urgently took the action of adjusting the valuation.
BOC Fund issued the suggestive announcement on valuation changes of some of its funds. The announcement said that through consultation with the fund custodian of relevant funds, BOC fund decided to adjust the valuation of shares Xi’An International Medical Investment Company Limited(000516) (000516) held by some of its funds (except ETF funds) from January 13, 2022, and the valuation price was adjusted to RMB 7.11.
Coincidentally, GF also adjusted the valuation of Xi’An International Medical Investment Company Limited(000516) on the same day. According to the announcement of GF, since January 13, 2022, GF revalued Xi’An International Medical Investment Company Limited(000516) held by its securities investment fund, and the valuation price was adjusted to 7.11 yuan.
On Saturday (January 15), CITIC Prudential and Golden Eagle Fund followed up to reduce the valuation. Among them, CITIC Prudential reduced its valuation to 7.18 yuan / share, and Golden Eagle Fund reduced its valuation to 7.11 yuan.
Compared with the closing price of 8.37 yuan on January 13, the valuation price of 7.11 yuan has decreased by 15.05%, and if it is valued at 7.18 yuan, it has decreased by 14.22% compared with the latest closing price.
According to the third quarterly report of the fund, by the end of the third quarter, a total of 19 funds, including GF growth selection, BOC China selection, GF advantage growth, Huabao innovation selection and CNOOC high-quality growth, held Xi’An International Medical Investment Company Limited(000516) , a total of 88856200 shares, and the market value of positions at the end of the period exceeded 1 billion yuan. Among them, five funds including GF growth selection, ICBC Credit Suisse Frontier Medical, GF Jufeng, Huabao CSI medical ETF and BOC China selection ranked among the top ten circulating shareholders of Xi’An International Medical Investment Company Limited(000516) at the end of the third quarter.
However, whether the relevant funds have changed positions in the recent decline, whether there will be more fund companies to adjust the valuation of Xi’An International Medical Investment Company Limited(000516) remains to be disclosed by the latest announcement.
The abbreviation of the stock opened on 17 was changed to “St Guoyi”
the share price has fallen by more than 25% in the last eight trading days
Recently, a maternal abortion in Xi’an high tech hospital has aroused widespread concern. At present, the health and Health Commission of Shaanxi Province and Xi’an city has organized experts to investigate and determined that the incident is a liability accident. Xi’an high tech hospital has dealt with the relevant responsible persons: Fan Yuhui, general manager, has been suspended, and the relevant responsible persons of the outpatient department and medical department have been removed.
On January 13, Xi’An International Medical Investment Company Limited(000516) announced that the subordinate Xi\’an high tech hospital (hereinafter referred to as “high tech hospital”) and Xi\’an Xi’An International Medical Investment Company Limited(000516) Central Hospital (hereinafter referred to as “Central Hospital”) received the notice of Xi\’an Health Committee on the handling of Xi\’an high tech hospital and Xi\’an Xi’An International Medical Investment Company Limited(000516) Central hospital (hereinafter referred to as “notice”) on January 13, 2022. The notice is mainly for high tech hospital The central hospital will give a warning and suspend business for rectification for 3 months. After the rectification is qualified, it will reopen, and the person in charge of the hospital will be investigated for responsibility.
Xi’An International Medical Investment Company Limited(000516) said that the closure of the company’s high-tech hospital and central hospital for three months is expected to have a significant impact on the company’s operating performance in 2022. According to the relevant provisions of 9.1.5 and 9.8.1 of the stock listing rules of Shenzhen Stock Exchange (revised in 2022), the trading of the company’s shares will be suspended for one trading day on January 14, 2022, Other risk warnings shall be implemented from the date of resumption. The company will strive to take various measures to meet the requirements of revoking other risk warnings as soon as possible. After the corresponding circumstances are eliminated, the company will timely announce and apply to Shenzhen stock exchange for revoking other risk warnings.
Other risk warnings have been implemented for the company’s shares since the opening of the market on January 17, 2022. The abbreviation of the company’s shares has been changed from ” Xi’An International Medical Investment Company Limited(000516) ” to “St Guoyi”, the stock code is still “000516”, and the rise and fall of the stock trading day is limited to 5%.
In fact, since the “pregnant women’s abortion” incident broke out on January 4, the stock price of Xi’An International Medical Investment Company Limited(000516) has been falling continuously since January 5. The intraday stock price plummeted by more than 9% on January 6, and it was a sudden drop in the limit on January 13. The dragon and tiger list on that day showed that the institutions collectively “fled”. Among the top five seats sold, four were special seats for institutions, with a total sales of about 200 million yuan.
As of the closing on January 14, Xi’An International Medical Investment Company Limited(000516) 8 trading days had fallen by more than 25%. At present, the total market value is about 19 billion yuan, which “evaporates” more than 6.6 billion yuan compared with the closing on January 4.
two “involved” hospitals are Xi’An International Medical Investment Company Limited(000516) important revenue sources
According to the data, Xi’An International Medical Investment Company Limited(000516) company, formerly known as Xi’an Jiefang Department store, was founded in 1956. It is the largest department store retail enterprise in Xi’an and Shaanxi Province. In 2018, the company sold 100% equity of its wholly-owned subsidiary Kaiyuan Commercial Co., Ltd. to Yintai Department Store Co., Ltd., which has been successfully completed. After stripping the retail business assets of department stores, the company successfully realized the overall business strategic transformation and will focus on the development of the main business of medical services.
Xi’An International Medical Investment Company Limited(000516) the financial report shows that the company currently focuses on large-scale health medical services and the transformation and application of modern medical technology. At present, the company is operating large-scale comprehensive medical institutions such as Xi’an Xi’An International Medical Investment Company Limited(000516) high tech hospital, Xi’an Xi’An International Medical Investment Company Limited(000516) Central Hospital and Xi’an Xi’An International Medical Investment Company Limited(000516) Shangluo hospital, and is building Xi’an Xi’An International Medical Investment Company Limited(000516) rehabilitation hospital according to class III standard.
The two “involved” hospitals are Xi’An International Medical Investment Company Limited(000516) important revenue and profit sources. According to the disclosure of Xi’An International Medical Investment Company Limited(000516) 2021 interim report, the operating revenue of high tech hospital and Central Hospital in the first half of 2021 was 538 million yuan and 717 million yuan respectively. The total revenue of the two hospitals accounted for more than 90% of the operating revenue of Xi’An International Medical Investment Company Limited(000516) in the same period.
